Deficiencies In Healthcare Provision ExposedJune 11, 2004Serious deficiencies in the healthcare provision for people with arthritis / rheumatism were exposed today in the results of a new European survey. More than 100 million people in Europe are affected by arthritis / rheumatism, making it Europe's most widespread chronic disease. The condition can have serious consequences, ranging from severe pain to loss of mobility, and delays in diagnosis and treatment have been shown to increase the risk of further joint damage. In addition, although over half of the respondents in the survey said their condition had a major impact on their ability to work,1 only 34 per cent said they had convenient access to occupational therapy and 44 per cent to rehabilitation.1 Undertaken by the People with Arthritis / Rheumatism in Europe (PARE) Manifesto Steering Group, a body representing the EULAR Social Leagues (patient groups), the survey also showed a significant impact on quality of life, with more than 50 per cent of people stating it had a moderate or major impact on relationships with family and friends.1 In addition, although arthritis / rheumatism is a long-term condition, less than two out of ten people with arthritis / rheumatism questioned in the survey thought that they were very well-informed about it, while four out of ten people felt fairly well-informed.1 Speaking at the European League Against Rheumatism (EULAR) medical congress, Dr Neil Betteridge, Chair of the PARE Manifesto Steering Group, said that the results of the survey revealed a need to improve access to information and healthcare provision. "The pain and disability of arthritis / rheumatism affects every aspect of life and it has serious consequences for society, but despite this, many people do not have access to appropriate treatment and support," he said. Dissatisfaction with treatment was also a problem - a quarter of those surveyed were dissatisfied with the treatment their doctor prescribed and only a quarter were very or extremely satisfied. Poor pain relief (59 per cent) and unpleasant side-effects (43 per cent) were the major reasons for lack of contentment.1 Gastrointestinal (GI) side-effects were cited as by far the most common side-effect (32 per cent).1 GI side-effects are commonly associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), a common treatment for arthritis / rheumatism. The survey involved 617 people with arthritis / rheumatism from seven European countries, (France, Germany, Hungary, Italy, The Netherlands, Sweden and the UK). - ends - Notes for Editors The study was initially conducted as an online survey via the PARE Manifesto web site, www.paremanifesto.org, and with the support of PARE Manifesto's national patient groups. Respondents were screened to make sure that they could only complete the survey once. A telephone line was also set up in each country for people with arthritis / rheumatism who did not have access to the internet or who could not type for long periods of time. This meant that they could be interviewed by telephone and their views included in the results. The telephone number was advertised through media releases and patient flyers distributed by general practitioners, rheumatologists, pharmacists and in outpatient clinics in hospitals. 250 of the 617 people who completed the survey, were interviewed by telephone. | |||||||||||||||||||||
|
Related Arthritis Current Events and Arthritis News Articles Groundbreaking, inexpensive, pocket-sized ultrasound device can help treat cancer, relieve arthritis A prototype of a therapeutic ultrasound device, developed by a Cornell graduate student, fits in the palm of a hand, is battery-powered and packs enough punch to stabilize a gunshot wound or deliver drugs to brain cancer patients. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia. Potential autoimmunity-inducing cells found in healthy adults It's not just patients with autoimmune diseases like lupus and rheumatoid arthritis (RA) that have self-attacking immune cells-healthy people have them too, according to a new report in the Journal of Experimental Medicine. Patients with severe psoriasis need evaluation of heart disease risk According to new recommendations in the December 10 issue of The American Journal of Cardiology (AJC), published by Elsevier, new research is called for and patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD). Vitamin D deficiency in infants and nursing mothers carries long-term disease risks Once believed to be important only for bone health, vitamin D is now seen as having a critical function in maintaining the immune system throughout life. Mathematical models of adaptive immunity More than five million people die every year from infectious diseases, despite the availability of numerous antibiotics and vaccines. Gene therapy effective treatment against gum disease Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults. Pine bark reduces inflammatory marker CRP in osteoarthritis Osteoarthritis (OA), a type of arthritis caused by the breakdown and loss of cartilage, affects more than 20 million Americans. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. More Arthritis Current Events and Arthritis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||